Go to JAX® Mice Query Form

Strain Name:

FVB-Tg(ACTA1-PABPN1*A17)1Drub/J

Stock Number:

006655

Availability:

Repository- Live


General Terms and Conditions

Former Name      FVB-Tg(ACTA1-PABPN1*17)1Drub/J    (Changed: 11-JAN-07 )
Genes & Alleles   ACTA1;   PABPN1;   Tg(ACTA1-PABPN1*A17)1Drub;


Product Information

Strain Details

Type JAX® GEMM® Strain - Coisogenic
Additional information on JAX® GEMM® Strains.
Type JAX® GEMM® Strain - Mutant Strain
Type JAX® GEMM® Strain - Transgenic
Mating System+/+ sibling x Hemizygote         (Female x Male)
Specieslaboratory mouse
Donating Investigator David Rubinsztein,   Cambridge Institute for Medical Research
GenerationN1+1F1 (12-DEC-07)

Strain Description
Mice hemizygous for the transgenic insert are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities until roughly four months of age. At four months, hemizygotes develop a time-dependent progressive muscle weakness (measured by grip strength, wire maneuver and vertical gripping tests), which leads to late onset locomoter defects around 9 months of age. At 9 months mice can not lift their own body weight. They drag their pelvis when walking and show reluctance to walk. There is no difference in body weight or mortality up to 15 months of age compared to controls. Hemizygotes develop KCl-insoluble inclusions containing PABPN1 in the nuclei of skeletal muscle fibers with tubulo-filamentous ultrastructures. The proportion of myocte nuclei with aggregates increases with age. Significantly elevated numbers of TUNEL-positive myocyte nuclei can be found at 6 and 12 months. TUNEL staining is widely used as a cell-death marker in muscle diseases in mice and humans. Muscles of hemizygotes contain increased numbers of centrally located nuclei and vacuoles compared to controls, which reflects the regenerative processes that can result from muscular dystrophy. This strain my prove useful as a model of human Oculopharyngeal Muscular Dystrophy and in Muscular Dystrophy or Codon Reiteration Disease research.

Strain Development
A transgenic construct containing a human skeletal actin (HSA1) promoter upstream of a bovine poly-(A) binding protein nuclear 1 (PABPN1) with 17 alanines was injected into FVB donor eggs.

Related Disease (OMIM) Terms

Oculopharyngeal Muscular Dystrophy; OPMD
Mammalian Phenotype Terms assigned by genotype

Tg(ACTA1-PABPN1*A17)1Drub/0

        involves: FVB/N
  • behavior/neurological phenotype
  • abnormal grip strength (MGI Ref ID J:115642)
    • mutants display age-dependent decreases in grip strength compared to nontransgenic controls from 2-15 months of age
    • in male mice treated with doxycycline (DOX) from 6 weeks of age, grip strength and vertical gripping is improved compared to nontreated transgenic mice
  • abnormal locomotor activation (MGI Ref ID J:115642)
    • mutants show reluctance to walk from ~9 months
  • abnormal motor coordination/ balance (MGI Ref ID J:115642)
    • from ~9 months of age, mutants cannot lift their bodies, dragging the pelvis when walking
    • late-stage locomotor defects are improved with DOX treatment at 9 and 10 months compared to placebo treatment
  • muscle phenotype
  • abnormal skeletal muscle fiber morphology (MGI Ref ID J:115642)
    • proportion of myocyte nuclei with tubulo-filamentous ultrastructures and containing KCl-insoluble aggregates increases with age, compared to nontransgenic controls
    • mutants have increased numbers of apoptotic myocyte nuclei compared to controls at 6-12 months
    • musle has increased numbers of centrally located nuclei and vacuoules
    • aggregate formation is decreased with DOX treatment and number of apoptotic nuclei is reduced
  • muscle weakness (MGI Ref ID J:115642)
    • progressive muscle weakness (MGI Ref ID J:115642)
      • mutant display weakness assessed by grip strength, wire maneuver and vertical gripping , leading to locomotor deficits

Gene & Allele Details

Allele Symbol Tg(ACTA1-PABPN1*A17)1Drub
Allele Name transgene insertion 1, David Rubinsztein
Common Name(s) A17-1;
Strain of OriginFVB/N
Expressed Gene PABPN1, poly(A) binding protein, nuclear 1, human
Promoter ACTA1, actin, alpha 1, skeletal muscle, human
General Note Of two lines descended from founders with this transgenic construct, line A7-1 has a more severe phenotype, correlated with higher transgene expression levels, than line A7-2.
Molecular Note The transgene contains the human skeletal actin promoter upstream of a mutant bovine cDNA with a series of CGC codons encoding a 17-amino acid polyalanine tract. [MGI Ref ID J:115642]

Control Information

  Control
   Noncarrier
   001800 FVB/NJ
 
  Considerations for Choosing Controls

Genotyping Protocols

Tg(ACTA1-PABPN1*A17)1Drub

Colony Maintenance

Diet Information LabDiet® 5K52/5K67

Related Strains

View Strains carrying other alleles of ACTA1     (7 strains)

Animal Health Reports

Room Number           AX11

Research Applications

This mouse can be used to support research in many areas including:

Neurobiology Research
Neuromuscular Defects

References

Selected Reference(s)

Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC. 2005. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat Med 11(6):672-7. [PubMed: 15864313]  [MGI Ref ID J:115642]

Additional References

Price and Supply Information

Strain Name: FVB-Tg(ACTA1-PABPN1*A17)1Drub/J
Stock Number: 006655

Price Details

IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.

*NO Shipping Destination selected!

 

Supply Details

Standard SupplyRepository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement.
Supply Notes Usually shipped between four and eight weeks of age.
This strain is included in the Induced Mutant Resource Colony collection.
LicensingSee General Terms and Conditions below  
Control InformationView Control Information in Strain Details.

General Terms and Conditions

View JAX® Mice & Services Conditions of Use.

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering and Purchasing Information

      Purchasing Information
      JAX® Mice Orders
      Surgical Services

Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form

Go to JAX® Mice Query Form

(2.15)